184 related articles for article (PubMed ID: 31318911)
1. K121Q polymorphism in the Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 gene is associated with acute kidney rejection.
Sortica DA; Crispim D; Bauer AC; Nique PS; Nicoletto BB; Crestani RP; Staehler JT; Manfro RC; Canani LH
PLoS One; 2019; 14(7):e0219062. PubMed ID: 31318911
[TBL] [Abstract][Full Text] [Related]
2. Association of the ENPP1 K121Q polymorphism with type 2 diabetes and obesity in the Moroccan population.
El Achhab Y; Meyre D; Bouatia-Naji N; Berraho M; Deweirder M; Vatin V; Delplanque J; Serhier Z; Lyoussi B; Nejjari C; Froguel P; Chikri M
Diabetes Metab; 2009 Feb; 35(1):37-42. PubMed ID: 19046915
[TBL] [Abstract][Full Text] [Related]
3. [The analysis of association between ENPP1 K121Q polymorphism and risk factors of type 2 diabetes mellitus in ukrainian population].
Marchenko IV; Dubovyk YI; Matlai OI; Biesiedina AA; Kniazkova PV; Harbuzova YA
Wiad Lek; 2018; 71(4):815-820. PubMed ID: 30099416
[TBL] [Abstract][Full Text] [Related]
4. Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study.
Stolerman ES; Manning AK; McAteer JB; Dupuis J; Fox CS; Cupples LA; Meigs JB; Florez JC
Diabetes; 2008 Jul; 57(7):1971-7. PubMed ID: 18426862
[TBL] [Abstract][Full Text] [Related]
5. Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysis.
Sortica DA; Buffon MP; Souza BM; Nicoletto BB; Santer A; Assmann TS; Crispim D; Canani LH
PLoS One; 2015; 10(3):e0118416. PubMed ID: 25794151
[TBL] [Abstract][Full Text] [Related]
6. The K121Q polymorphism of ENPP1 and peripheral arterial disease.
Eller P; Schgoer W; Mueller T; Tancevski I; Demetz E; Duwensee K; Ritsch A; Haltmayer M; Patsch JR
Heart Vessels; 2008 Mar; 23(2):104-7. PubMed ID: 18389334
[TBL] [Abstract][Full Text] [Related]
7. The ENPP1 K121Q polymorphism modulates developing of bone disorders in type 2 diabetes: A cross sectional study.
Neamati N; Hosseini SR; Hajiahmadi M; Halalkhor S; Nooreddini H; Niaki HA; Korani B; Parsian H
Gene; 2017 Dec; 637():100-107. PubMed ID: 28942038
[TBL] [Abstract][Full Text] [Related]
8. The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.
Moore AF; Jablonski KA; Mason CC; McAteer JB; Arakaki RF; Goldstein BJ; Kahn SE; Kitabchi AE; Hanson RL; Knowler WC; Florez JC;
J Clin Endocrinol Metab; 2009 Feb; 94(2):449-55. PubMed ID: 19017751
[TBL] [Abstract][Full Text] [Related]
9. Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.
Takahama Y; Uto H; Kanmura S; Oketani M; Ido A; Kusumoto K; Hasuike S; Nagata K; Hayashi K; Stuver S; Okayama A; Tsubouchi H
J Gastroenterol; 2008; 43(12):942-50. PubMed ID: 19107338
[TBL] [Abstract][Full Text] [Related]
10. ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: a meta-analysis including 11,855 subjects.
Li YY
Metabolism; 2012 May; 61(5):625-33. PubMed ID: 22136912
[TBL] [Abstract][Full Text] [Related]
11. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes in North Indians.
Bhatti JS; Bhatti GK; Mastana SS; Ralhan S; Joshi A; Tewari R
Mol Cell Biochem; 2010 Dec; 345(1-2):249-57. PubMed ID: 20820885
[TBL] [Abstract][Full Text] [Related]
12. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
[TBL] [Abstract][Full Text] [Related]
13. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population.
Saberi H; Mohammadtaghvaei N; Gulkho S; Bakhtiyari S; Mohammadi M; Hanachi P; Gerayesh-Nejad S; Zargari M; Ataei F; Parvaneh L; Larijani B; Meshkani R
Mol Cell Biochem; 2011 Apr; 350(1-2):113-8. PubMed ID: 21153685
[TBL] [Abstract][Full Text] [Related]
14. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study.
Meyre D; Bouatia-Naji N; Vatin V; Veslot J; Samson C; Tichet J; Marre M; Balkau B; Froguel P
Diabetologia; 2007 Oct; 50(10):2090-6. PubMed ID: 17704904
[TBL] [Abstract][Full Text] [Related]
15. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
Bochenski J; Placha G; Wanic K; Malecki M; Sieradzki J; Warram JH; Krolewski AS
Diabetes; 2006 Sep; 55(9):2626-30. PubMed ID: 16936213
[TBL] [Abstract][Full Text] [Related]
16. Association of K121Q Polymorphism in Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 with Clinical Characteristics of Metabolic Syndrom.
Li N; Pan H; Cui M; Li Q
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):313-7. PubMed ID: 27219689
[TBL] [Abstract][Full Text] [Related]
17. ENPP1/PC-1 gene K121Q polymorphism is associated with obesity in European adult populations: evidence from a meta-analysis involving 24,324 subjects.
Wang R; Zhou D; Xi B; Ge X; Zhu P; Wang B; Zhou M; Huang Y; Liu J; Yu Y; Wang C
Biomed Environ Sci; 2011 Apr; 24(2):200-6. PubMed ID: 21565692
[TBL] [Abstract][Full Text] [Related]
18. The Q121 variant of ENPP1 may protect from childhood overweight/obesity in the Italian population.
Morandi A; Pinelli L; Petrone A; Vatin V; Buzzetti R; Froguel P; Meyre D
Obesity (Silver Spring); 2009 Jan; 17(1):202-6. PubMed ID: 18948963
[TBL] [Abstract][Full Text] [Related]
19. Association of K121Q polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults.
Matsuoka N; Patki A; Tiwari HK; Allison DB; Johnson SB; Gregersen PK; Leibel RL; Chung WK
Int J Obes (Lond); 2006 Feb; 30(2):233-7. PubMed ID: 16231022
[TBL] [Abstract][Full Text] [Related]
20. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM
Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
